Walleye Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,289
| Closed | -$2.69M | – | 4400 |
|
|
2025
Q1 | $2.83M | Sell |
25,289
-75,777
| -75% | -$7.82M | 0.01% | 1416 |
|
|
2024
Q4 | $9.34M | Sell |
101,066
-1,656
| -2% | -$149K | 0.02% | 822 |
|
|
2024
Q3 | $8.61M | Buy |
102,722
+9,949
| +11% | +$759K | 0.02% | 851 |
|
|
2024
Q2 | $6.37M | Buy |
+92,773
| New | +$6.19M | 0.02% | 933 |
|
|
2024
Q1 | – | Sell |
-10,465
| Closed | -$805K | – | 4985 |
|
|
2023
Q4 | $848K | Sell |
10,465
-128,852
| -92% | -$10M | ﹤0.01% | 2623 |
|
|
2023
Q3 | $10.4M | Buy |
139,317
+123,531
| +783% | +$9.5M | 0.03% | 670 |
|
|
2023
Q2 | $1.22M | Sell |
15,786
-10,545
| -40% | -$841K | ﹤0.01% | 2008 |
|
|
2023
Q1 | $2.18M | Sell |
26,331
-96,827
| -79% | -$8.02M | ﹤0.01% | 1610 |
|
|
2022
Q4 | $10.6M | Buy |
+123,158
| New | +$9.75M | 0.03% | 637 |
|
|
2022
Q2 | – | Sell |
-58,794
| Closed | -$3.64M | – | 5328 |
|
|
2022
Q1 | $3.5M | Sell |
58,794
-76,851
| -57% | -$4.91M | 0.01% | 1235 |
|
|
2021
Q4 | $9.85M | Buy |
135,645
+33,097
| +32% | +$2.28M | 0.03% | 613 |
|
|
2021
Q3 | $7.16M | Buy |
+102,548
| New | +$7.2M | 0.03% | 725 |
|
|
2021
Q1 | – | Sell |
-87,677
| Closed | -$5.65M | – | 4975 |
|
|
2020
Q4 | $5.11M | Buy |
87,677
+47,896
| +120% | +$2.89M | 0.02% | 720 |
|
|
2020
Q3 | $2.51M | Buy |
39,781
+9,020
| +29% | +$626K | 0.01% | 973 |
|
|
2020
Q2 | $2.37M | Sell |
30,761
-25,178
| -45% | -$1.93M | 0.02% | 974 |
|
|
2020
Q1 | $4.18M | Sell |
55,939
-36,707
| -40% | -$2.54M | 0.03% | 468 |
|
|
2019
Q4 | $6.02M | Buy |
92,646
+54,803
| +145% | +$3.57M | 0.04% | 478 |
|
|
2019
Q3 | $2.4M | Buy |
37,843
+27,069
| +251% | +$1.77M | 0.02% | 898 |
|
|
2019
Q2 | $728K | Sell |
10,774
-9,588
| -47% | -$631K | 0.01% | 1873 |
|
|
2019
Q1 | $1.32M | Sell |
20,362
-52,970
| -72% | -$3.52M | 0.01% | 1414 |
|
|
2018
Q4 | $4.59M | Buy |
73,332
+32,808
| +81% | +$2.29M | 0.03% | 524 |
|
|
2018
Q3 | $3.13M | Sell |
40,524
-21,558
| -35% | -$1.63M | 0.02% | 961 |
|
|
2018
Q2 | $4.4M | Sell |
62,082
-107,401
| -63% | -$7.58M | 0.02% | 693 |
|
|
2018
Q1 | $12.8M | Buy |
169,483
+161,750
| +2,092% | +$12.9M | 0.07% | 191 |
|
|
2017
Q4 | $554 | Sell |
7,733
-86,443
| -92% | -$6.56M | ﹤0.01% | 2510 |
|
|
2017
Q3 | $7.63K | Buy |
94,176
+39,301
| +72% | +$3.01M | 0.04% | 433 |
|
|
2017
Q2 | $3.88K | Sell |
54,875
-31,300
| -36% | -$2.08M | 0.02% | 744 |
|
|
2017
Q1 | $5.85K | Buy |
86,175
+40,025
| +87% | +$2.81M | 0.04% | 415 |
|
|
2016
Q4 | $3.31M | Buy |
+46,150
| New | +$3.43M | 0.02% | 643 |
|
|
2016
Q3 | – | Sell |
-44,770
| Closed | -$3.64M | – | 5047 |
|
|
2016
Q2 | $3.73M | Buy |
+44,770
| New | +$3.97M | 0.02% | 608 |
|
|
2016
Q1 | – | Sell |
-74,156
| Closed | -$6.69M | – | 5504 |
|
|
2015
Q4 | $7.5M | Buy |
74,156
+65,385
| +745% | +$6.8M | 0.07% | 258 |
|
|
2015
Q3 | $861K | Buy |
+8,771
| New | +$974K | 0.01% | 1165 |
|
|
2015
Q2 | – | Sell |
-68,043
| Closed | -$7.44M | – | 4945 |
|
|
2015
Q1 | $6.68M | Buy |
68,043
+11,125
| +20% | +$1.13M | 0.07% | 233 |
|
|
2014
Q4 | $5.37M | Buy |
56,918
+47,024
| +475% | +$4.86M | 0.05% | 296 |
|
|
2014
Q3 | $1.05M | Buy |
+9,894
| New | +$969K | 0.01% | 792 |
|
|
2014
Q1 | – | Sell |
-38,283
| Closed | -$3M | – | 3666 |
|
|
2013
Q4 | $2.88M | Buy |
+38,283
| New | +$2.67M | 0.03% | 490 |
|
Other funds holding GILD
VCM
VPM
Walleye Trading's GILD Position: Q2 2025 in Review
Walleye Trading sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 25,289 shares — an estimated $2.69M sold.
Walleye Trading first reported a position in GILD in Q4 2013 and held it in 36 quarters. The position peaked at $12.8M in Q1 2018. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- Walleye Trading reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 25,289 Gilead Sciences shares in Q2 2025, an estimated $2.69M.
- Walleye Trading first reported a position in Gilead Sciences in Q4 2013 and held it in 36 quarters.
- Walleye Trading's Gilead Sciences position peaked at $12.8M in Q1 2018.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.